0 31/03/2023 2023-03-31 false false false false false false false false false false true false false true false false false false true true false No description of principal activities is disclosed 2022-04-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 08455647 2022-04-01 2023-03-31 08455647 2023-03-31 08455647 2021-04-01 2022-03-31 08455647 2022-03-31 08455647 core:PlantMachinery 2022-04-01 2023-03-31 08455647 core:MotorVehicles 2022-04-01 2023-03-31 08455647 bus:Director2 2022-04-01 2023-03-31 08455647 core:LandBuildings core:ShortLeaseholdAssets 2022-03-31 08455647 core:FurnitureFittingsToolsEquipment 2022-03-31 08455647 core:MotorVehicles 2022-03-31 08455647 core:LandBuildings core:ShortLeaseholdAssets 2023-03-31 08455647 core:FurnitureFittingsToolsEquipment 2023-03-31 08455647 core:MotorVehicles 2023-03-31 08455647 core:WithinOneYear 2023-03-31 08455647 core:WithinOneYear 2022-03-31 08455647 core:ShareCapital 2023-03-31 08455647 core:ShareCapital 2022-03-31 08455647 core:RevaluationReserve 2023-03-31 08455647 core:RevaluationReserve 2022-03-31 08455647 core:RetainedEarningsAccumulatedLosses 2023-03-31 08455647 core:RetainedEarningsAccumulatedLosses 2022-03-31 08455647 core:LandBuildings core:ShortLeaseholdAssets 2022-04-01 2023-03-31 08455647 core:FurnitureFittingsToolsEquipment 2022-04-01 2023-03-31 08455647 core:CostValuation core:Non-currentFinancialInstruments 2022-03-31 08455647 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-03-31 08455647 core:DisposalsRepaymentsInvestments core:Non-currentFinancialInstruments 2023-03-31 08455647 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2023-03-31 08455647 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 08455647 core:Non-currentFinancialInstruments 2023-03-31 08455647 core:Non-currentFinancialInstruments 2022-03-31 08455647 core:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal core:Non-currentFinancialInstruments 2023-03-31 08455647 core:LandBuildings core:ShortLeaseholdAssets 2022-03-31 08455647 core:FurnitureFittingsToolsEquipment 2022-03-31 08455647 core:MotorVehicles 2022-03-31 08455647 bus:SmallEntities 2022-04-01 2023-03-31 08455647 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 08455647 bus:FullAccounts 2022-04-01 2023-03-31 08455647 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 08455647 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31
Company registration number: 08455647
Cumbria Medical Services Limited
Unaudited filleted financial accounts
For the year ended
31 March 2023
Cumbria Medical Services Limited
Contents
Statement of financial position
Notes to the financial accounts
Cumbria Medical Services Limited
Statement of financial position
31 March 2023
2023 2022
Note £ £ £ £
Fixed assets
Tangible assets 4 66,438 92,618
Investments 5 533,757 741,803
________ ________
600,195 834,421
Current assets
Stocks 6,900 6,100
Debtors 6 1,104,588 931,335
Cash at bank and in hand 167,934 161,744
________ ________
1,279,422 1,099,179
Creditors: amounts falling due
within one year 7 ( 204,611) ( 245,451)
________ ________
Net current assets 1,074,811 853,728
________ ________
Total assets less current liabilities 1,675,006 1,688,149
Provisions for liabilities
Deferred taxation ( 13,394) ( 14,997)
________ ________
Net assets 1,661,612 1,673,152
________ ________
Capital and reserves
Called up share capital 1,051 1,050
Fair value reserve 8 117,556 105,097
Profit and loss account 8 1,543,005 1,567,005
________ ________
Shareholders funds 1,661,612 1,673,152
________ ________
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial accounts for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial accounts.
These financial accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial accounts were approved by the board of directors and authorised for issue on 04 October 2023 , and are signed on behalf of the board by:
Dr M J White
Director
Company registration number: 08455647
Cumbria Medical Services Limited
Notes to the financial accounts
Year ended 31 March 2023
1. Accounting policies
Statutory information
These financial accounts have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same financial statements.
Cumbria Medical Services Limited is a private company, limited by shares, domiciled in England and Wales, registration number 08455647 . The registered office is Oxford Chambers, New Oxford Street, Workington, CA14 2LR.
Basis of preparation
The financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A small entities. There were no material departures from that standard.
Turnover
Turnover consists of the sales value, excluding VAT, of all work done in the period under contracts to supply services to third parties. It includes the relevant proportion of contract values where work is partially performed in the period.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Tangible assets
Tangible fixed assets are included at cost less depreciation.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery - 20 % straight line
Motor vehicles - 25 % straight line
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Fixed asset investments
Fixed asset investments are initially measured at fair value, which is normally the transaction price. Investments are subsequently carried at fair value with changes in fair value being recognised in the statement of comprehensive income.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Stocks
Stocks are valued at the lower of cost and net realisable value.
Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received.
Government grants are recognised using the accrual model and the performance model.
Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.
Deferred taxation
Deferred taxation is provided on the liability method to take account of timing differences between the treatment of certain items for accounts purposes and their treatment for tax purposes. Tax deferred or accelerated is accounted for in respect of all material timing differences.
Financial instruments
Basic financial instruments are recognised at amortised cost, except for fixed asset investments which are measured at fair value, with changes recognised in the fair value reserve.
2. Employee numbers
The average number of persons employed by the company during the year amounted to Nil (2022: Nil).
3. Income from other fixed asset investments
2023 2022
£ £
Income from other fixed asset investments 6,403 9,668
Profit on disposal of fixed asset investments (3,374) 34,849
________ ________
3,029 44,517
________ ________
4. Tangible assets
Short leasehold property Fixtures, fittings and equipment Motor vehicles Total
£ £ £ £
Cost
At 1 April 2022 10,695 84,389 100,003 195,087
Additions 740 12,137 - 12,877
________ ________ ________ ________
At 31 March 2023 11,435 96,526 100,003 207,964
________ ________ ________ ________
Depreciation
At 1 April 2022 1,070 47,904 53,495 102,469
Charge for the year 1,144 12,911 25,002 39,057
________ ________ ________ ________
At 31 March 2023 2,214 60,815 78,497 141,526
________ ________ ________ ________
Carrying amount
At 31 March 2023 9,221 35,711 21,506 66,438
________ ________ ________ ________
At 31 March 2022 9,625 36,485 46,508 92,618
________ ________ ________ ________
5. Investments
Other investments other than loans Total
£ £
Cost or valuation
At 1 April 2022 741,802 741,802
Additions 19,072 19,072
Disposals ( 224,582) ( 224,582)
Revaluations ( 2,535) ( 2,535)
________ ________
At 31 March 2023 533,757 533,757
________ ________
Impairment
At 1 April 2022 and 31 March 2023 - -
________ ________
Carrying amount
At 31 March 2023 533,757 533,757
________ ________
At 31 March 2022 741,802 741,802
________ ________
Investments held at valuation
In respect of investments held at valuation, the comparable carrying amount that would have been recognised if the assets had been carried under the historical cost model are as follows:
Other investments other than loans Total
£ £
At 31 March 2023
Aggregate cost 416,201 416,201
Aggregate depreciation - -
________ ________
Carrying amount 416,201 416,201
________ ________
At 31 March 2022
Aggregate cost 636,706 636,706
Aggregate depreciation - -
________ ________
Carrying amount 636,706 636,706
________ ________
6. Debtors
2023 2022
£ £
Trade debtors 79,869 46,926
Other debtors 1,024,719 884,409
________ ________
1,104,588 931,335
________ ________
7. Creditors: amounts falling due within one year
2023 2022
£ £
Trade creditors 43,843 25,349
Corporation tax 111,206 147,599
Other creditors 49,562 72,503
________ ________
204,611 245,451
________ ________
8. Reserves
The fair value reserve is in respect of the recognition of listed investments at market value. The fair value reserve is non distributable.
9. Directors advances, credits and guarantees
During the year the company made advances to Dr F L Chaudhri, a director, totalling £1,395l (2022 - £nil). Repayments of £nil were made by 31 March 2023 and so the balance outstanding at the year end, 31 March 2023, was £2,800 (2022 - £1,405). During the year the company made advances to Dr M J White , a director, totalling £nil (2022 - £3, 618). Repayments of £31,122 were made by 31 March 2023 and so the balance outstanding at the year end, 31 March 2023, was £615,511 (2022 - £646,633). Where applicable, interest is charged on overdrawn loan accounts at the rate of 2% per annum, loans are repayable on demand.